WO2022268755A1 - Use of a cosmetic composition for preventing and/or treating cutaneous blackheads - Google Patents
Use of a cosmetic composition for preventing and/or treating cutaneous blackheads Download PDFInfo
- Publication number
- WO2022268755A1 WO2022268755A1 PCT/EP2022/066791 EP2022066791W WO2022268755A1 WO 2022268755 A1 WO2022268755 A1 WO 2022268755A1 EP 2022066791 W EP2022066791 W EP 2022066791W WO 2022268755 A1 WO2022268755 A1 WO 2022268755A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- blackheads
- acid
- cutaneous
- cosmetic
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 99
- 206010000496 acne Diseases 0.000 title claims abstract description 84
- 239000002537 cosmetic Substances 0.000 title claims abstract description 43
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims abstract description 62
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 claims abstract description 31
- 229940055577 oleyl alcohol Drugs 0.000 claims abstract description 31
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 29
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 27
- 229930195729 fatty acid Natural products 0.000 claims abstract description 27
- 239000000194 fatty acid Substances 0.000 claims abstract description 27
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 23
- 150000002632 lipids Chemical class 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000000470 constituent Substances 0.000 claims abstract description 13
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 24
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 24
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 24
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 24
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 24
- 239000005642 Oleic acid Substances 0.000 claims description 20
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 20
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 13
- 230000000699 topical effect Effects 0.000 claims description 9
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 8
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 claims description 8
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 7
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 6
- 239000011607 retinol Substances 0.000 claims description 5
- 229960003471 retinol Drugs 0.000 claims description 5
- 235000020944 retinol Nutrition 0.000 claims description 5
- 235000021357 Behenic acid Nutrition 0.000 claims description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 4
- 235000021355 Stearic acid Nutrition 0.000 claims description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 4
- 229940114079 arachidonic acid Drugs 0.000 claims description 4
- 235000021342 arachidonic acid Nutrition 0.000 claims description 4
- 229940116226 behenic acid Drugs 0.000 claims description 4
- 235000020778 linoleic acid Nutrition 0.000 claims description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 4
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 4
- 150000002889 oleic acids Chemical class 0.000 claims description 4
- 239000008117 stearic acid Substances 0.000 claims description 4
- 229960004274 stearic acid Drugs 0.000 claims description 4
- DTOSIQBPPRVQHS-UHFFFAOYSA-N α-Linolenic acid Chemical compound CCC=CCC=CCC=CCCCCCCCC(O)=O DTOSIQBPPRVQHS-UHFFFAOYSA-N 0.000 claims description 4
- KOGFZZYPPGQZFZ-QVAPDBTGSA-N (2s,3r,4s,5r)-2-(2-hydroxypropyl)oxane-3,4,5-triol Chemical compound CC(O)C[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O KOGFZZYPPGQZFZ-QVAPDBTGSA-N 0.000 claims description 3
- 210000001061 forehead Anatomy 0.000 claims description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 3
- 229960004889 salicylic acid Drugs 0.000 claims description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 26
- 150000001875 compounds Chemical class 0.000 description 14
- 235000021314 Palmitic acid Nutrition 0.000 description 13
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 9
- 239000003921 oil Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 208000002874 Acne Vulgaris Diseases 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000004090 dissolution Methods 0.000 description 6
- 102000011782 Keratins Human genes 0.000 description 5
- 108010076876 Keratins Proteins 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000003349 gelling agent Substances 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- -1 alkyl lactates Chemical class 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 210000002374 sebum Anatomy 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 229940100554 isononyl isononanoate Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- PTPDZZWUOHQSLG-UHFFFAOYSA-N 2-octyldodecyl 2,2-dimethylpropanoate Chemical compound CCCCCCCCCCC(COC(=O)C(C)(C)C)CCCCCCCC PTPDZZWUOHQSLG-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- SZAMSYKZCSDVBH-CLFAGFIQSA-N [(z)-octadec-9-enyl] (z)-docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC SZAMSYKZCSDVBH-CLFAGFIQSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 229940100609 all-trans-retinol Drugs 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000003280 chronobiological effect Effects 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 210000000736 corneocyte Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 239000002973 irritant agent Substances 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229940120511 oleyl erucate Drugs 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
Definitions
- the present invention relates to the field of cosmetic products, more particularly intended for the prevention and/or treatment of cutaneous blackheads.
- It also relates to a cosmetic method, in particular a non-therapeutic method, comprising the application, to the skin to be treated, of a composition containing at least one active principle in accordance with the invention.
- Cutaneous blackheads in particular on the face, concern all skin typologies. Due to their black, indeed even brown, color, they are highly visible, all the more so on lightly pigmented skin, and, as such, are generally regarded as unattractive and thus undesirable.
- a cutaneous blackhead results from the process of comedogenesis which affects pilosebaceous units of sebaceous follicle type, which are distributed predominantly on the face.
- comedogenesis causes distension of the hair canal, sebum retention and excessive comification of the pilosebaceous duct.
- Hypercornification results in sebum retention and in the accumulation of cell debris.
- Keratin and keratotic plugs are clusters of corneocytes, in particular clusters of proteins. They are colourless, while blackheads are, as their name suggests, black or dark brown. As such, while keratin plugs may be present in blackheads, they are not responsible for the black or brown colour of the comedones.
- JP 2018/021084 which relates to a liquid cosmetic cleansing composition in the form of an emulsion for extracting the proteins which adhere to the skin.
- Solutions are also already available for treating blackheads. These solutions generally target accumulation of cell debris and sebum retention by an action of desquamation of the surface of the open comedo.
- Some of these solutions consist of physical methods based on the use, for example, of comedo suction device, of comedo extractor or of self-adhesive patches to be removed. For obvious reasons, these methods have an aggressive nature with regard to the skin, are not painless and are capable of generating unattractive skin irritation or red marks.
- the present invention results more particularly from the characterization by the inventors of novel active principles which are particularly effective with regard to blackheads and which advantageously prove to be devoid of the abovementioned disadvantages.
- the present invention relates to the cosmetic use of at least one Ci 8 fatty acid or alcohol chosen from isostearic acid, oleyl alcohol and their mixtures for dissolving all or part of the constituent lipids of cutaneous comedones and/or blackheads.
- the cosmetic use of at least one Cis fatty acid or alcohol chosen from isostearic acid, oleyl alcohol and their mixtures proves to be very particularly effective in preventing the appearance of cutaneous blackheads and/or removing cutaneous comedones and blackheads.
- isostearic acid and/or oleyl alcohol is/are employed in combination with at least one fatty acid chosen from oleic, linolenic, linoleic, behenic, arachidonic and stearic acid and in particular with at least oleic acid.
- isostearic acid and oleyl alcohol prove to be capable of dissolving lipid substances constituting cutaneous comedones and blackheads and thus are shown to be particularly effective in preventing the appearance of blackheads and/or removing these blackheads.
- the present invention relates to a cosmetic method for dissolving all or part of the constituent lipids of cutaneous comedones and/or blackheads, comprising the application, to the skin to be treated, of at least one Cis fatty acid or alcohol chosen from isostearic acid, oleyl alcohol and their mixtures.
- the cosmetic method in accordance with the invention is of use in preventing the appearance of cutaneous blackheads and/or removing cutaneous comedones and blackheads.
- the cosmetic uses and methods considered according to the invention are nontherapeutic.
- the uses and methods considered herein for dissolving all or part of the constituent lipids of cutaneous comedones and/or blackheads are exclusively cosmetic.
- the present application does not imply that at least one Cis fatty acid or alcohol chosen from isostearic acid, oleyl alcohol and their mixtures could be used for therapeutic purposes.
- the uses and methods of the invention do not require an expertise or prescription from a medical professional, and may be implemented by any individual wishing to prevent or eliminate inaesthetic imperfections such as blackheads. Again, this is a clear indication that the uses and methods of the invention are nontherapeutic.
- the skin is understood to denote, within the meaning of the present invention, all of the skin of the body, excluding the scalp and the mucous membranes.
- the skin is the skin of the face and/or of the body, in particular of the face and/or of the hands, preferably of the face, and more particularly of the forehead and/or of the alae of the nose and/or of the chin.
- the skin is greasy and/or glistening skin, in particular skin exhibiting excessive secretion and excretion of sebum.
- the skin is in particular greasy and/or glistening skin, especially of phototype 1, 2, 3 or 4, in particular greasy and/or glistening skin of the face and/or of the hands, more particularly greasy and/or glistening skin of the forehead and/or of the alae of the nose and/or of the chin.
- the skin is nonacneic skin, namely healthy skin devoid of the clinical manifestations of acne, namely acne lesions, such as the presence of numerous acne pimples.
- the blackheads constitute cutaneous imperfections of the skin, distinct from ailments of the skin, such as acne.
- the blackhead is not an inflammatory lesion of the skin, in contrast to the lesions characteristic of acne.
- the regions of the face which are favorable to the development of blackheads, namely more particularly the alae of the nose precisely do not constitute regions partial to the development of acne.
- composition suitable for the invention is Composition suitable for the invention.
- the isostearic acid, the oleyl alcohol or one of their mixtures is employed in the form of a cosmetic composition containing it which is suitable for a topical application.
- the cosmetic composition comprises from 0.1% to 20% by weight, preferably from 0.2% to 10% by weight, better still from 0.5% to 5.0% by weight, more preferentially still from 1% to 3% by weight, of isostearic acid and/or of oleyl alcohol, with respect to its total weight.
- isostearic acid and/or oleyl alcohol When employed in the form of a composition, they are formulated therein in a physiologically acceptable medium. Such a medium is considered to be physiologically acceptable when it does not cause any tingling, tautness or discomfort unacceptable for the user.
- isostearic acid and/or oleyl alcohol is/are employed with at least one fatty acid chosen from oleic, linolenic, linoleic, behenic, arachidonic and stearic acid and in particular with at least oleic acid.
- the use according to the invention can employ isostearic acid and/or oleyl alcohol in combination with at least one of the abovementioned fatty acids in an isostearic acid and/or oleyl alcohol/a fatty acid chosen from oleic, linolenic, linoleic, behenic, arachidonic and stearic acid and their mixtures ratio by weight varying from 10/90 to 90/10, 80/20 to 20/80, 40/60 to 60/40 or also 50/50.
- a composition suitable for the invention contains at least isostearic acid and oleic acid in particular in an isostearic acid/oleic acid ratio by weight varying from 10/90 to 90/10, 80/20 to 20/80, 40/60 to 60/40 or also 50/50.
- a composition suitable for the invention contains at least oleyl alcohol and oleic acid in particular in an oleyl alcohol/oleic acid ratio by weight varying from 10/90 to 90/10, 80/20 to 20/80, 40/60 to 60/40 or also 50/50.
- a composition suitable for the invention contains at least isostearic acid, oleic acid and oleyl alcohol in particular in an isostearic acid + oleyl alcohol/oleic acid ratio by weight varying from 10/90 to 90/10, 80/20 to 20/80, 40/60 to 60/40 or also 50/50.
- a composition suitable for the invention can be provided in any formulation form normally used in the cosmetics field.
- aqueous or aqueous/alcoholic solution which is optionally gelled, of a dispersion of the lotion type, which is optionally a two-phase lotion, of an oil-in-water or water-in-oil or multiple emulsion, of an aqueous gel, of a dispersion of oils in an aqueous phase, in particular by means of spherules, it being possible for these spherules to be polymer particles or, better still, lipid vesicles of ionic and/or non-ionic type, or else in the form of a powder, of a serum, of a paste or of a flexible rod or also of a stick. It can be of solid, pasty or more or less fluid liquid consistency.
- composition can comprise any constituent normally employed in the topical application and administration envisaged.
- Mention may in particular be made of water, solvents, compounds forming a fatty phase which is liquid at ambient temperature, for example oils of mineral, animal and/or vegetable origin, waxes, in particular, pigments, fillers, surfactants, thickeners, gelling agents, preservatives and their mixtures in all proportions.
- oils for example oils of mineral, animal and/or vegetable origin, waxes, in particular, pigments, fillers, surfactants, thickeners, gelling agents, preservatives and their mixtures in all proportions.
- a composition suitable for the invention can advantageously be provided in the form of an emulsion, in particular obtained by dispersion of an aqueous phase in a fatty phase (W/O) or of a fatty phase in an aqueous phase (O/W), of liquid or semi-liquid consistency of the milk type, or of soft, semi- solid or solid consistency of the cream or gel type, or also of multiple emulsion (W/O/W or O/W/O).
- W/O a fatty phase
- O/W aqueous phase
- composition can advantageously comprise at least one fatty phase which is liquid at ambient temperature and atmospheric pressure.
- Such a fatty phase can comprise at least one nonvolatile ether oil having from 10 to 40 carbon atoms and/or at least one nonvolatile monoester oil.
- nonvolatile oil is understood to denote an oil, the vapor pressure of which at ambient temperature and atmospheric pressure is nonzero and less than 10 3 mmHg (0.13 Pa).
- ethers having from 10 to 40 carbon atoms of dicaprylyl ether (CTFA name: Dicaprylyl ether).
- the amount of fatty phase which is liquid at ambient temperature and atmospheric pressure present in the compositions according to the invention can range, for example, from 0.01% to 50% by weight and preferably from 0.1% to 30% by weight, with respect to the total weight of the composition.
- the emulsions according to the invention can comprise at least one emulsifier chosen from amphoteric, anionic, cationic or nonionic emulsifiers, used alone or as a mixture.
- the emulsifiers are appropriately chosen according to the emulsion to be obtained (W/O or O/W).
- the emulsifiers are generally present in the composition in a proportion which can range from 0.3% to 30% by weight and preferably from 0.5% to 20% by weight, with respect to the total weight of the composition.
- O/W emulsions for example, as emulsifiers, of nonionic surfactants, and in particular esters of polyols and of fatty acids having a saturated or unsaturated chain comprising, for example, from 8 to 24 carbon atoms and better still from 12 to 22 carbon atoms, and their oxyalkylenated derivatives, that is to say derivatives comprising oxy ethylene and/or oxypropylene units, for example the esters of glycerol and of C 8 -C 24 fatty acids, and their oxyalkylenated derivatives; the esters of polyethylene glycol and of C 8 -C 24 fatty acids, and their oxyalkylenated derivatives; the esters of sorbitol and of C 8 -C 24 fatty acids, and their oxyalkylenated derivatives; the esters of sugar (sucrose, glucose or alkylglucose) and of C 8 -C 24 fatty acids, and their esters of sugar (suc
- a composition suitable for the invention can additionally comprise at least one silicone elastomer, in particular the products sold under the KSG names by Shin-Etsu, under the Trefil, BY29 or EPSX names by Dow Coming or under the Gransil names by Grant Industries.
- a composition suitable for the invention can additionally contain one or more adjuvants commonly used in the cosmetics field, in particular sequestering agents, odor absorbers, UV- screening agents, fragrances, mattifying agents, and abrasive fillers or exfoliating agents, and their mixtures in all proportions.
- adjuvants commonly used in the cosmetics field in particular sequestering agents, odor absorbers, UV- screening agents, fragrances, mattifying agents, and abrasive fillers or exfoliating agents, and their mixtures in all proportions.
- a composition used according to the invention can advantageously comprise at least one additional active principle.
- the additional active principles may be selected from those commonly employed in the art of cosmetic formulation.
- additional active principle is understood to mean, in the context of the present invention, a compound which has, by itself, that is to say not requiring the intervention of an external agent in order to activate it, a biological activity which can in particular be:
- an astringent activity and/or - an activity intended to combat and/or prevent the signs of aging, in particular chronobiological aging, for example wrinkles and fine lines.
- the additional active principle which can be used in the compositions of the invention is preferentially chosen from agents which dissolve supplementary lipid compounds, desquamating agents, soothing agents, anti-irritant agents, sebum-regulating or anti- seborrheic agents, astringent agents and their mixtures in all proportions.
- this additional agent is at least oleic acid.
- It can also be at least one active principle for caring for greasy skin.
- the additional active principle for caring for greasy skin used in a composition suitable for the invention can represent from 0.0001% to 20%, preferably from 0.01% to 10% and better still from 0.01% to 5% by weight, with respect to the total weight of the composition. Mention may in particular be made, as specific example of other additional active principles, of salicylic acid and pro-xylane, in particular extracted from rye seeds.
- composition employed according to the invention can advantageously comprise from 5% to 80% by weight and preferably from 35% to 75% by weight of water, with respect to the total weight of said composition.
- the pH of said composition is advantageously less than or equal to 8, preferably ranging from 4 to 7, limits included, better still ranging from 4.5 to 6.5, limits included.
- a composition suitable for the invention can additionally comprise retinol, otherwise known as vitamin A, preferably all-trans-retinol.
- composition suitable for the invention can comprise an amount of retinol ranging from 0.02% to 5.0% by weight, in particular from 0.05% to 3.0% by weight, with respect to the total weight of the composition.
- composition employed in a use or a method according to the invention can comprise at least one active principle, in particular chosen from oleic acid, salicylic acid, pro-xylane, retinol and their mixtures.
- a composition suitable for the invention can additionally comprise at least one polyol, namely an organic molecule comprising at least two free hydroxyl groups, in particular chosen from ethylene glycol, propylene glycol, 1,3-propanediol, 1,3-butylene glycol, isoprene glycol, 1,2-pentylene glycol, hexylene glycol, caprylyl glycol, dipropylene glycol, glycerol, pentaerythritol, trimethylolpropane, polyglycerols, polyethylene glycols and their mixtures.
- polyol namely an organic molecule comprising at least two free hydroxyl groups, in particular chosen from ethylene glycol, propylene glycol, 1,3-propanediol, 1,3-butylene glycol, isoprene glycol, 1,2-pentylene glycol, hexylene glycol, caprylyl glycol, dipropylene glycol, glycerol, pentaery
- a composition suitable for the invention can additionally comprise at least one gelling agent, in particular a hydrophilic gelling agent, namely a compound capable of gelling the aqueous phase of the compositions suitable for the invention.
- a hydrophilic gelling agent namely a compound capable of gelling the aqueous phase of the compositions suitable for the invention.
- hydrophilic gelling agents of the polymers and copolymers of 2-acrylamido-2- methylpropanesulfonic acid, which are crosslinked and/or neutralized, polysaccharides and their mixtures.
- a composition suitable for the invention can also comprise at least one derivative of polyethylene glycol and of mono-, di- and triglycerides of an acid comprising at least one alkyl chain ranging from Ce to C 1 ⁇ 2 , and having at least two ethylene oxide groups, in particular chosen from derivatives of polyethylene glycol and of mono-, di- and triglycerides of caprylic acid and of capric acid, for example that comprising 6 ethylene oxide groups (INCI name: PEG-6 caprylic/capric glycerides), sold under the name Softigen 767 by Sasol. It can also comprise at least one colorant chosen, for example, from pigments, pearlescent agents, dyes, effect materials and their mixtures in all proportions. These colorants can be present in a content ranging from 0.01% to 50% by weight and preferably from 0.01% to 30% by weight, with respect to the total weight of the composition.
- a composition suitable for the invention can additionally comprise at least one filler, in particular in a content ranging from 0.01% to 50% by weight, preferably ranging from 0.01% to 30% by weight, with respect to the total weight of the composition.
- These fillers can be inorganic or organic and of any shape, platelet, spherical or oblong, whatever the crystallographic form (for example sheet, cubic, hexagonal, orthorhombic or amorphous).
- a composition of the invention can advantageously exhibit a firm and compact feel when taken up. It can be thick on application and subsequently be transformed, melt and release freshness.
- a composition of the invention can advantageously be provided in the form of a more or less wide stick, such as a pencil, for example.
- a composition can alternatively have the form of a product for caring for or making up the face and/or the body, and be packaged, for example, in the form of cream in ajar or of fluid in a tube or as a pump- action spray.
- a composition according to the invention can be manufactured by any known process generally used in the cosmetics field.
- the ingredients are mixed before they are shaped, in the order and under conditions which are easily determined by a person skilled in the art.
- the present invention relates to a cosmetic method for dissolving all or part of the constituent lipids of cutaneous comedones and blackheads, comprising the application, to the skin, of a cosmetic composition comprising at least isostearic acid and/or oleyl alcohol and, if appropriate, oleic acid.
- Such a method proves to be very particularly useful for preventing the appearance of blackheads and/or removing cutaneous comedones and/or blackheads.
- the cosmetic method of the invention is carried out by administering, by the topical route, a composition comprising at least isostearic acid and/or oleyl alcohol and, if appropriate, oleic acid, preferably in a physiologically acceptable medium.
- the administration consists of the external application to the skin of cosmetic compositions according to the usual techniques for use of these compositions.
- the cosmetic method according to the invention can be carried out by topical application, for example daily, of at least one fatty acid or alcohol in accordance with the invention which can, for example, be formulated in the form of a cream, gel, serum, lotion, emulsion, make-up-removing milk, stick or aftersun composition.
- the application is repeated, for example, 2 to 3 times daily for one day or more and generally over an extended period of at least 4 weeks, indeed even 4 to 15 weeks, with, if appropriate, one or more periods of interruption.
- the application is daily (once per day) and generally over an extended period of at least 4 weeks, indeed even 4 to 15 weeks, with, if appropriate, one or more periods of interruption.
- the composition including at least isostearic acid and/or oleyl alcohol and, if appropriate, oleic acid is applied to skin regions which have been cleansed beforehand, for example using an appropriate soap, and/or freed beforehand from at least one blackhead, for example using an adhesive patch or a mechanical action.
- treatment combinations with optionally supplementary topical forms, in order to complement or to reinforce the activity of the isostearic acid and/or oleyl alcohol can be envisaged.
- this distinct active principle is oleic acid.
- the present invention also relates to a cosmetic method for dissolving all or part of the constituent lipids of cutaneous comedones and/or blackheads, comprising: a) a stage of application, to the skin, of a cosmetic composition comprising at least one Cis fatty acid and/or alcohol chosen from isostearic acid, oleyl alcohol or one of their mixtures; and b) a stage of application, to said skin treated in a), of a composition different from said composition of stage a) and containing at least one active principle distinct from that of the composition a).
- Such a composition applied in stage b) can be described as "supplementary composition”.
- Stages a) and b) defined above can be carried out simultaneously or successively.
- This supplementary composition which is different from the composition suitable for the invention, and applicable by the topical route, can in particular be in the form of an emulsified oil-in-water gel, comprising at least one compound chosen from oleic acid or retinol; polyols; hydrophilic gelling agents; derivatives of polyethylene glycol and of mono- , di- and triglycerides of an acid comprising at least one alkyl chain ranging from Ce to C 1 ⁇ 2 , and having at least two ethylene oxide groups; nonvolatile ether oils having from 10 to 40 carbon atoms; and nonvolatile monoester oils.
- an emulsified oil-in-water gel comprising at least one compound chosen from oleic acid or retinol; polyols; hydrophilic gelling agents; derivatives of polyethylene glycol and of mono- , di- and triglycerides of an acid comprising at least one alkyl chain ranging from Ce to C 1 ⁇ 2 , and having at least two
- DSC measurements were carried out by studying mixtures according to the following ratio by weight: 20% by weight of palmitic acid + 80% by weight of the compound to be tested.
- the measurements are carried out on a TA Instruments DSC Q100, in high-pressure stainless steel crucibles of approximately 20 pi with a leaktight seal.
- the crucible containing the sample to be characterized is introduced into an oven at ambient temperature and then equilibrated at 10°C. It is subsequently heated to 80°C with a gradient at 5°C/min. An isotherm is applied for 5 min. This first cycle represents the first melting of the palmitic acid. The temperature is then brought down to 10°C with a gradient of 5°C/min. This second cycle marks the recrystallization of the palmitic acid. Finally, the crucible is heated to 80°C with a gradient at 5°C/min. This last cycle represents the second melting of the palmitic acid. The objective of this measurement is to identify if the compound tested is a good solvent for palmitic acid by shifting the melting peak toward a lower temperature in the second melting. The percentage of palmitic acid molten at 32°C (surface temperature of the skin) could thus be determined for each compound tested as solvent.
- the microscopic observations are carried out between slide and cover slip by means of a Leica DMLB microscope which is used in transmission mode.
- the preparation of the samples consists in putting 0.0017 g of palmitic acid and then one drop of the compound to be tested on a slide with spacer placed on a heating stage at 32°C during the microscopic observation (at xlO magnification) over a total duration of 24 h.
- the state of dissolution of the palmitic acid crystals is characterized by microscopic observation (xlO). 3) Characterization of the dissolution of the lipid components of comedones by microscopic observation.
- isostearic acid and oleyl alcohol show the most significant effectivenesses with regard to the dissolution of constituent lipids of comedones. Brought into contact with each of these two compounds, the comedones lose in density and thus diminish in volume.
- Oleic acid although having a lower effectiveness, also has a dissolving power with regard to the constituent lipids of comedones.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Use of a cosmetic composition for preventing and/or treating cutaneous blackheads The present invention relates to the use of at least one C18 fatty acid or alcohol chosen from isostearic acid, oleyl alcohol and their mixtures for dissolving all or part of the constituent lipids of cutaneous comedones and/or blackheads. It additionally targets a corresponding cosmetic method.
Description
Description
Title: Use of a cosmetic composition for preventing and/or treating cutaneous blackheads
Technical field
The present invention relates to the field of cosmetic products, more particularly intended for the prevention and/or treatment of cutaneous blackheads.
It also relates to a cosmetic method, in particular a non-therapeutic method, comprising the application, to the skin to be treated, of a composition containing at least one active principle in accordance with the invention.
Prior art
Cutaneous blackheads, in particular on the face, concern all skin typologies. Due to their black, indeed even brown, color, they are highly visible, all the more so on lightly pigmented skin, and, as such, are generally regarded as unattractive and thus undesirable.
To date, it is accepted that the cutaneous blackhead results from the process of comedogenesis which affects pilosebaceous units of sebaceous follicle type, which are distributed predominantly on the face. From a clinical perspective, a cutaneous blackhead is an open comedo (noninflammatory lesion) characterized by distension of the hair canal, sebum retention and excessive comification of the pilosebaceous duct. Hypercornification results in sebum retention and in the accumulation of cell debris.
Cutaneous blackheads and comedones are different from keratin and keratotic plugs. Keratin and keratotic plugs are clusters of corneocytes, in particular clusters of proteins. They are colourless, while blackheads are, as their name suggests, black or dark brown. As such, while keratin plugs may be present in blackheads, they are not responsible for the black or brown colour of the comedones.
Solutions against keratin and keratotic plugs exist in the art and mainly offer a keratolytic action which helps detach and eliminate keratin from the skin. These compositions eliminate dead skin, therefore tackling the superficial layers that surround the blackhead, but do not act directly on the comedones or blackheads.
Examples of such compositions are provided in JP 2018/021084 which relates to a liquid cosmetic cleansing composition in the form of an emulsion for extracting the proteins which
adhere to the skin. Mention may also be made of US 2012/073591 which describes a method for cleansing the skin by removing solid impurities such as keratotic plugs comprising several steps of massaging the skin with different compositions.
Solutions are also already available for treating blackheads. These solutions generally target accumulation of cell debris and sebum retention by an action of desquamation of the surface of the open comedo.
Some of these solutions consist of physical methods based on the use, for example, of comedo suction device, of comedo extractor or of self-adhesive patches to be removed. For obvious reasons, these methods have an aggressive nature with regard to the skin, are not painless and are capable of generating unattractive skin irritation or red marks.
Other solutions are based more particularly on the treatment of the blackheads with an active principle capable of detrimentally affecting them and/or eliminating them, in particular by acting on their coloration. By way of illustration of these active principles, mention may in particular be made of antioxidants, such as, for example, glutathione (GSH), ascorbic acid (vitamin C) or cysteine described in the patent FR 3 044 905 Bl. However, a number of these active principles have the drawback of detrimentally affecting the organoleptic properties of the composition comprising them, in particular the odor and/or the color of the composition, over time. Active principles capable of dissolving constituent lipids of blackheads, such as alkyl lactates, described in the patent US 4 540 567, or else neutralized fatty acids, such as described in the patent application EP 3 150 187, have also been provided.
The present invention results more particularly from the characterization by the inventors of novel active principles which are particularly effective with regard to blackheads and which advantageously prove to be devoid of the abovementioned disadvantages.
Summary of the invention
Thus, according to a first aspect, the present invention relates to the cosmetic use of at least one Ci8 fatty acid or alcohol chosen from isostearic acid, oleyl alcohol and their mixtures for dissolving all or part of the constituent lipids of cutaneous comedones and/or blackheads.
Thus, the cosmetic use of at least one Cis fatty acid or alcohol chosen from isostearic acid, oleyl alcohol and their mixtures proves to be very particularly effective in preventing the appearance of cutaneous blackheads and/or removing cutaneous comedones and blackheads. According to a specific alternative form, isostearic acid and/or oleyl alcohol is/are employed in combination with at least one fatty acid chosen from oleic, linolenic, linoleic, behenic, arachidonic and stearic acid and in particular with at least oleic acid.
As emerges from the examples which appear below, the inventors have, contrary to all expectations, found that isostearic acid and oleyl alcohol prove to be capable of dissolving lipid substances constituting cutaneous comedones and blackheads and thus are shown to be particularly effective in preventing the appearance of blackheads and/or removing these blackheads.
According to another of its aspects, the present invention relates to a cosmetic method for dissolving all or part of the constituent lipids of cutaneous comedones and/or blackheads, comprising the application, to the skin to be treated, of at least one Cis fatty acid or alcohol chosen from isostearic acid, oleyl alcohol and their mixtures.
In particular, the cosmetic method in accordance with the invention is of use in preventing the appearance of cutaneous blackheads and/or removing cutaneous comedones and blackheads.
The cosmetic uses and methods considered according to the invention are nontherapeutic.
In particular, the uses and methods considered herein for dissolving all or part of the constituent lipids of cutaneous comedones and/or blackheads are exclusively cosmetic. The present application does not imply that at least one Cis fatty acid or alcohol chosen from isostearic acid, oleyl alcohol and their mixtures could be used for therapeutic purposes. In particular, the uses and methods of the invention do not require an expertise or prescription from a medical professional, and may be implemented by any individual wishing to prevent or eliminate inaesthetic imperfections such as blackheads. Again, this is a clear indication that the uses and methods of the invention are nontherapeutic.
The term "the skin" is understood to denote, within the meaning of the present invention, all of the skin of the body, excluding the scalp and the mucous membranes. Preferably, the skin is the skin of the face and/or of the body, in particular of the face and/or of the hands, preferably of the face, and more particularly of the forehead and/or of the alae of the nose and/or of the chin.
According to a first alternative form, the skin is greasy and/or glistening skin, in particular skin exhibiting excessive secretion and excretion of sebum. According to this alternative form, the skin is in particular greasy and/or glistening skin, especially of phototype 1, 2, 3 or 4, in particular greasy and/or glistening skin of the face and/or of the hands, more particularly greasy and/or glistening skin of the forehead and/or of the alae of the nose and/or of the chin.
According to a second alternative form, the skin is nonacneic skin, namely healthy skin devoid of the clinical manifestations of acne, namely acne lesions, such as the presence of numerous acne pimples. This is because the blackheads constitute cutaneous imperfections of the skin, distinct from ailments of the skin, such as acne. In particular, the blackhead is not an inflammatory lesion of the skin, in contrast to the lesions characteristic of acne. Furthermore, the regions of the face which are favorable to the development of blackheads, namely more particularly the alae of the nose, precisely do not constitute regions partial to the development of acne.
Detailed description of the invention
Composition suitable for the invention
According to one aspect of the invention, the isostearic acid, the oleyl alcohol or one of their mixtures is employed in the form of a cosmetic composition containing it which is suitable for a topical application.
Advantageously, in this cosmetic use, the cosmetic composition comprises from 0.1% to 20% by weight, preferably from 0.2% to 10% by weight, better still from 0.5% to 5.0% by weight, more preferentially still from 1% to 3% by weight, of isostearic acid and/or of oleyl alcohol, with respect to its total weight.
When isostearic acid and/or oleyl alcohol are employed in the form of a composition, they are formulated therein in a physiologically acceptable medium. Such a medium is considered to be physiologically acceptable when it does not cause any tingling, tautness or discomfort unacceptable for the user.
As specified above, according to a specific alternative form, isostearic acid and/or oleyl alcohol is/are employed with at least one fatty acid chosen from oleic, linolenic, linoleic, behenic, arachidonic and stearic acid and in particular with at least oleic acid.
In this alternative embodiment, the use according to the invention can employ isostearic acid and/or oleyl alcohol in combination with at least one of the abovementioned fatty acids in an isostearic acid and/or oleyl alcohol/a fatty acid chosen from oleic, linolenic, linoleic, behenic, arachidonic and stearic acid and their mixtures ratio by weight varying from 10/90 to 90/10, 80/20 to 20/80, 40/60 to 60/40 or also 50/50.
According to a specific alternative form, a composition suitable for the invention contains at least isostearic acid and oleic acid in particular in an isostearic acid/oleic acid ratio by weight varying from 10/90 to 90/10, 80/20 to 20/80, 40/60 to 60/40 or also 50/50.
According to another specific alternative form, a composition suitable for the invention contains at least oleyl alcohol and oleic acid in particular in an oleyl alcohol/oleic acid ratio by weight varying from 10/90 to 90/10, 80/20 to 20/80, 40/60 to 60/40 or also 50/50. According to another specific alternative form, a composition suitable for the invention contains at least isostearic acid, oleic acid and oleyl alcohol in particular in an isostearic acid + oleyl alcohol/oleic acid ratio by weight varying from 10/90 to 90/10, 80/20 to 20/80, 40/60 to 60/40 or also 50/50.
A composition suitable for the invention can be provided in any formulation form normally used in the cosmetics field.
It can in particular be in the form of an aqueous or aqueous/alcoholic solution, which is optionally gelled, of a dispersion of the lotion type, which is optionally a two-phase lotion, of an oil-in-water or water-in-oil or multiple emulsion, of an aqueous gel, of a dispersion of oils in an aqueous phase, in particular by means of spherules, it being possible for these spherules to be polymer particles or, better still, lipid vesicles of ionic and/or non-ionic type, or else in the form of a powder, of a serum, of a paste or of a flexible rod or also of a stick. It can be of solid, pasty or more or less fluid liquid consistency.
Thus, the composition can comprise any constituent normally employed in the topical application and administration envisaged.
Mention may in particular be made of water, solvents, compounds forming a fatty phase which is liquid at ambient temperature, for example oils of mineral, animal and/or vegetable origin, waxes, in particular, pigments, fillers, surfactants, thickeners, gelling agents, preservatives and their mixtures in all proportions.
A composition suitable for the invention can advantageously be provided in the form of an emulsion, in particular obtained by dispersion of an aqueous phase in a fatty phase (W/O) or of a fatty phase in an aqueous phase (O/W), of liquid or semi-liquid consistency of the milk type, or of soft, semi- solid or solid consistency of the cream or gel type, or also of multiple emulsion (W/O/W or O/W/O). These compositions are prepared according to the usual methods.
The composition can advantageously comprise at least one fatty phase which is liquid at ambient temperature and atmospheric pressure.
Such a fatty phase can comprise at least one nonvolatile ether oil having from 10 to 40 carbon atoms and/or at least one nonvolatile monoester oil.
Within the meaning of the present invention, the term "nonvolatile oil" is understood to denote an oil, the vapor pressure of which at ambient temperature and atmospheric pressure is nonzero and less than 103 mmHg (0.13 Pa).
Mention may in particular be made, as example of ethers having from 10 to 40 carbon atoms, of dicaprylyl ether (CTFA name: Dicaprylyl ether).
Mention may in particular be made, as preferred monoesters, of isononyl isononanoate, oleyl erucate and/or 2-octyldodecyl neopentanoate, preferably isononyl isononanoate.
The amount of fatty phase which is liquid at ambient temperature and atmospheric pressure present in the compositions according to the invention, and taking into account the amounts of isostearic acid, oleyl alcohol and any other fatty acid capable of being combined with these, can range, for example, from 0.01% to 50% by weight and preferably from 0.1% to 30% by weight, with respect to the total weight of the composition.
The emulsions according to the invention can comprise at least one emulsifier chosen from amphoteric, anionic, cationic or nonionic emulsifiers, used alone or as a mixture. Advantageously, the emulsifiers are appropriately chosen according to the emulsion to be obtained (W/O or O/W). The emulsifiers are generally present in the composition in a proportion which can range from 0.3% to 30% by weight and preferably from 0.5% to 20% by weight, with respect to the total weight of the composition.
Mention may be made, for the O/W emulsions, for example, as emulsifiers, of nonionic surfactants, and in particular esters of polyols and of fatty acids having a saturated or unsaturated chain comprising, for example, from 8 to 24 carbon atoms and better still from 12 to 22 carbon atoms, and their oxyalkylenated derivatives, that is to say derivatives
comprising oxy ethylene and/or oxypropylene units, for example the esters of glycerol and of C8-C24 fatty acids, and their oxyalkylenated derivatives; the esters of polyethylene glycol and of C8-C24 fatty acids, and their oxyalkylenated derivatives; the esters of sorbitol and of C8-C24 fatty acids, and their oxyalkylenated derivatives; the esters of sugar (sucrose, glucose or alkylglucose) and of C8-C24 fatty acids, and their oxyalkylenated derivatives; the ethers of fatty alcohols; the ethers of sugar and of C8-C24 fatty alcohols; and their mixtures in all proportions.
A composition suitable for the invention can additionally comprise at least one silicone elastomer, in particular the products sold under the KSG names by Shin-Etsu, under the Trefil, BY29 or EPSX names by Dow Coming or under the Gransil names by Grant Industries.
A composition suitable for the invention can additionally contain one or more adjuvants commonly used in the cosmetics field, in particular sequestering agents, odor absorbers, UV- screening agents, fragrances, mattifying agents, and abrasive fillers or exfoliating agents, and their mixtures in all proportions.
A composition used according to the invention can advantageously comprise at least one additional active principle. The additional active principles may be selected from those commonly employed in the art of cosmetic formulation.
The inclusion of one or more additional active principles does not confer any therapeutic properties to the composition. As such, the uses and methods of the invention remain cosmetic and nontherapeutic even if one or more additional active principles are included in the composition.
The expression "additional active principle" is understood to mean, in the context of the present invention, a compound which has, by itself, that is to say not requiring the intervention of an external agent in order to activate it, a biological activity which can in particular be:
- a desquamating activity (which makes possible the opening of the comedones), and/or
- an antimicrobial activity (in particular with regard to P. acnes ), and/or
- a soothing or anti-irritant activity, and/or
- a sebum-regulating or anti- seborrheic activity, and/or
- an astringent activity, and/or
- an activity intended to combat and/or prevent the signs of aging, in particular chronobiological aging, for example wrinkles and fine lines.
The additional active principle which can be used in the compositions of the invention is preferentially chosen from agents which dissolve supplementary lipid compounds, desquamating agents, soothing agents, anti-irritant agents, sebum-regulating or anti- seborrheic agents, astringent agents and their mixtures in all proportions.
According to a specific alternative form, this additional agent is at least oleic acid.
It can also be at least one active principle for caring for greasy skin.
The additional active principle for caring for greasy skin used in a composition suitable for the invention can represent from 0.0001% to 20%, preferably from 0.01% to 10% and better still from 0.01% to 5% by weight, with respect to the total weight of the composition. Mention may in particular be made, as specific example of other additional active principles, of salicylic acid and pro-xylane, in particular extracted from rye seeds.
Moreover, a composition employed according to the invention can advantageously comprise from 5% to 80% by weight and preferably from 35% to 75% by weight of water, with respect to the total weight of said composition.
The pH of said composition is advantageously less than or equal to 8, preferably ranging from 4 to 7, limits included, better still ranging from 4.5 to 6.5, limits included.
A composition suitable for the invention can additionally comprise retinol, otherwise known as vitamin A, preferably all-trans-retinol.
More particularly, a composition suitable for the invention can comprise an amount of retinol ranging from 0.02% to 5.0% by weight, in particular from 0.05% to 3.0% by weight, with respect to the total weight of the composition.
Thus, a composition employed in a use or a method according to the invention can comprise at least one active principle, in particular chosen from oleic acid, salicylic acid, pro-xylane, retinol and their mixtures.
A composition suitable for the invention can additionally comprise at least one polyol, namely an organic molecule comprising at least two free hydroxyl groups, in particular chosen from ethylene glycol, propylene glycol, 1,3-propanediol, 1,3-butylene glycol, isoprene glycol, 1,2-pentylene glycol, hexylene glycol, caprylyl glycol, dipropylene glycol, glycerol, pentaerythritol, trimethylolpropane, polyglycerols, polyethylene glycols and their mixtures.
A composition suitable for the invention can additionally comprise at least one gelling agent, in particular a hydrophilic gelling agent, namely a compound capable of gelling the aqueous phase of the compositions suitable for the invention. Mention may be made, as examples of hydrophilic gelling agents, of the polymers and copolymers of 2-acrylamido-2- methylpropanesulfonic acid, which are crosslinked and/or neutralized, polysaccharides and their mixtures.
A composition suitable for the invention can also comprise at least one derivative of polyethylene glycol and of mono-, di- and triglycerides of an acid comprising at least one alkyl chain ranging from Ce to C½, and having at least two ethylene oxide groups, in particular chosen from derivatives of polyethylene glycol and of mono-, di- and triglycerides of caprylic acid and of capric acid, for example that comprising 6 ethylene oxide groups (INCI name: PEG-6 caprylic/capric glycerides), sold under the name Softigen 767 by Sasol. It can also comprise at least one colorant chosen, for example, from pigments, pearlescent agents, dyes, effect materials and their mixtures in all proportions. These colorants can be present in a content ranging from 0.01% to 50% by weight and preferably from 0.01% to 30% by weight, with respect to the total weight of the composition.
A composition suitable for the invention can additionally comprise at least one filler, in particular in a content ranging from 0.01% to 50% by weight, preferably ranging from 0.01% to 30% by weight, with respect to the total weight of the composition. These fillers can be inorganic or organic and of any shape, platelet, spherical or oblong, whatever the crystallographic form (for example sheet, cubic, hexagonal, orthorhombic or amorphous). Of course, a person skilled in the art will take care to choose the optional additional compound(s), and/or their amount, in such a way that the advantageous properties of the Cis fatty acid and/or alcohol which are required according to the invention are not, or not substantially, detrimentally affected by the envisaged addition and that the properties of the compositions resulting therefrom are compatible with the topical administration route.
A composition of the invention can advantageously exhibit a firm and compact feel when taken up. It can be thick on application and subsequently be transformed, melt and release freshness.
According to another alternative form, a composition of the invention can advantageously be provided in the form of a more or less wide stick, such as a pencil, for example.
A composition can alternatively have the form of a product for caring for or making up the face and/or the body, and be packaged, for example, in the form of cream in ajar or of fluid in a tube or as a pump- action spray.
A composition according to the invention can be manufactured by any known process generally used in the cosmetics field. The ingredients are mixed before they are shaped, in the order and under conditions which are easily determined by a person skilled in the art.
Cosmetic methods
As mentioned above, the present invention relates to a cosmetic method for dissolving all or part of the constituent lipids of cutaneous comedones and blackheads, comprising the application, to the skin, of a cosmetic composition comprising at least isostearic acid and/or oleyl alcohol and, if appropriate, oleic acid.
Such a method proves to be very particularly useful for preventing the appearance of blackheads and/or removing cutaneous comedones and/or blackheads.
The cosmetic method of the invention is carried out by administering, by the topical route, a composition comprising at least isostearic acid and/or oleyl alcohol and, if appropriate, oleic acid, preferably in a physiologically acceptable medium.
The administration consists of the external application to the skin of cosmetic compositions according to the usual techniques for use of these compositions.
By way of illustration, the cosmetic method according to the invention can be carried out by topical application, for example daily, of at least one fatty acid or alcohol in accordance with the invention which can, for example, be formulated in the form of a cream, gel, serum, lotion, emulsion, make-up-removing milk, stick or aftersun composition.
According to one embodiment, the application is repeated, for example, 2 to 3 times daily for one day or more and generally over an extended period of at least 4 weeks, indeed even 4 to 15 weeks, with, if appropriate, one or more periods of interruption.
According to another embodiment, the application is daily (once per day) and generally over an extended period of at least 4 weeks, indeed even 4 to 15 weeks, with, if appropriate, one or more periods of interruption.
According to another embodiment, the composition including at least isostearic acid and/or oleyl alcohol and, if appropriate, oleic acid is applied to skin regions which have been
cleansed beforehand, for example using an appropriate soap, and/or freed beforehand from at least one blackhead, for example using an adhesive patch or a mechanical action. Furthermore, treatment combinations with optionally supplementary topical forms, in order to complement or to reinforce the activity of the isostearic acid and/or oleyl alcohol, can be envisaged.
It might be possible to imagine a topical treatment with a composition containing at least isostearic acid and/or oleyl alcohol, combined with a supplementary composition dedicated to a topical application and containing at least one active principle distinct from isostearic acid and/or oleyl alcohol.
According to an alternative embodiment, this distinct active principle is oleic acid.
Thus, the present invention also relates to a cosmetic method for dissolving all or part of the constituent lipids of cutaneous comedones and/or blackheads, comprising: a) a stage of application, to the skin, of a cosmetic composition comprising at least one Cis fatty acid and/or alcohol chosen from isostearic acid, oleyl alcohol or one of their mixtures; and b) a stage of application, to said skin treated in a), of a composition different from said composition of stage a) and containing at least one active principle distinct from that of the composition a).
Such a composition applied in stage b) can be described as "supplementary composition". Stages a) and b) defined above can be carried out simultaneously or successively.
This supplementary composition, which is different from the composition suitable for the invention, and applicable by the topical route, can in particular be in the form of an emulsified oil-in-water gel, comprising at least one compound chosen from oleic acid or retinol; polyols; hydrophilic gelling agents; derivatives of polyethylene glycol and of mono- , di- and triglycerides of an acid comprising at least one alkyl chain ranging from Ce to C½, and having at least two ethylene oxide groups; nonvolatile ether oils having from 10 to 40 carbon atoms; and nonvolatile monoester oils.
Throughout the description, including the claims, the expressions "between ... and ...", "of between ... and ..." and "ranging from ... to ..." should be understood as meaning limits included, unless otherwise specified.
The examples which follow illustrate the present invention without limiting the scope thereof.
Materials and methods
The solubilizing effectiveness of the compounds tested was evaluated by targeting the dissolution of palmitic acid, which is the fatty acid predominantly present in blackheads, according to the following protocols:
1) By DSC measurement
In order to evaluate the satisfactory solvent potential of a starting material with regard to palmitic acid, DSC measurements were carried out by studying mixtures according to the following ratio by weight: 20% by weight of palmitic acid + 80% by weight of the compound to be tested.
The measurements are carried out on a TA Instruments DSC Q100, in high-pressure stainless steel crucibles of approximately 20 pi with a leaktight seal.
The crucible containing the sample to be characterized is introduced into an oven at ambient temperature and then equilibrated at 10°C. It is subsequently heated to 80°C with a gradient at 5°C/min. An isotherm is applied for 5 min. This first cycle represents the first melting of the palmitic acid. The temperature is then brought down to 10°C with a gradient of 5°C/min. This second cycle marks the recrystallization of the palmitic acid. Finally, the crucible is heated to 80°C with a gradient at 5°C/min. This last cycle represents the second melting of the palmitic acid. The objective of this measurement is to identify if the compound tested is a good solvent for palmitic acid by shifting the melting peak toward a lower temperature in the second melting. The percentage of palmitic acid molten at 32°C (surface temperature of the skin) could thus be determined for each compound tested as solvent.
2) Characterization of the dissolution of palmitic acid by microscopic observation in the presence of palmitic acid + the compound to be tested.
The microscopic observations are carried out between slide and cover slip by means of a Leica DMLB microscope which is used in transmission mode. The preparation of the samples consists in putting 0.0017 g of palmitic acid and then one drop of the compound to be tested on a slide with spacer placed on a heating stage at 32°C during the microscopic observation (at xlO magnification) over a total duration of 24 h. The state of dissolution of the palmitic acid crystals is characterized by microscopic observation (xlO).
3) Characterization of the dissolution of the lipid components of comedones by microscopic observation.
The samples were prepared precisely with the same equipment and methodology considered for the protocol 2), the palmitic acid being replaced with an ex vivo comedo. A detrimental change in the density of the comedo, exposed to contact with the compound to be tested, is indicative of a detrimental change in the integrity of this comedo and thus in the effectiveness of dissolution of the compound tested.
The results obtained for isostearic acid, oleyl alcohol and oleic acid are given in table 1 below.
As emerges from the above results, isostearic acid and oleyl alcohol show the most significant effectivenesses with regard to the dissolution of constituent lipids of comedones. Brought into contact with each of these two compounds, the comedones lose in density and thus diminish in volume.
Oleic acid, although having a lower effectiveness, also has a dissolving power with regard to the constituent lipids of comedones.
Claims
1. Cosmetic use of at least one Cis fatty acid or alcohol chosen from isostearic acid, oleyl alcohol and their mixtures for dissolving all or part of the constituent lipids of cutaneous comedones and/or blackheads.
2. Cosmetic use according to Claim 1, for preventing the appearance of cutaneous blackheads and/or removing cutaneous comedones and/or blackheads.
3. Cosmetic use according to Claim 1 or 2, employing said Cis fatty acid and/or alcohol in combination with at least one fatty acid chosen from oleic, linolenic, linoleic, behenic, arachidonic and stearic acid and in particular with at least oleic acid.
4. Cosmetic use according to any one of the preceding claims, in which said Cis fatty acid and/or alcohol is employed in the form of a cosmetic composition intended for a topical application.
5. Cosmetic use according to the preceding claim, in which said composition contains from 0.1% to 20% by weight, preferably from 0.2% to 10% by weight, better still from 0.5% to 5.0% by weight, more preferentially still from 1% to 3% by weight, of isostearic acid and/or of oleyl alcohol, with respect to its total weight.
6. Cosmetic use according to either one of Claims 4 and 5, in which said cosmetic composition further comprises at least one additional active principle, in particular chosen from oleic acid, salicylic acid, pro-xylane, retinol and their mixtures, and preferably at least oleic acid.
7. Cosmetic method for dissolving all or part of the constituent lipids of cutaneous comedones and/or blackheads, comprising the application, to the skin to be treated, of at least one Cis fatty acid or alcohol chosen from isostearic acid, oleyl alcohol and their mixtures.
8. Cosmetic method according to the preceding claim, useful for preventing the appearance of cutaneous blackheads and/or removing cutaneous comedones and/or blackheads.
9. Cosmetic method according to Claim 7 or 8, in which the skin is the skin of the face and/or of the body, in particular of the face and/or of the hands, preferably of the face, and more particularly of the forehead and/or of the alae of the nose and/or of the chin.
10. Cosmetic method for dissolving all or part of the constituent lipids of cutaneous comedones and/or blackheads, comprising: a) a stage of application, to the skin, of a cosmetic composition comprising at least one Ci8 fatty acid or alcohol chosen from isostearic acid, oleyl alcohol and their mixtures; and b) a stage of application, to said skin treated in a), of a composition different from said composition of stage a) and containing at least one active principle distinct from said fatty acid and/or alcohol.
11. Cosmetic method according to the preceding claim, for preventing the appearance of cutaneous blackheads and/or removing cutaneous comedones and/or blackheads.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FRFR2106830 | 2021-06-25 | ||
FR2106830A FR3124383A1 (en) | 2021-06-25 | 2021-06-25 | Use of a cosmetic composition for preventing and/or treating cutaneous blackheads. |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022268755A1 true WO2022268755A1 (en) | 2022-12-29 |
Family
ID=78536273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2022/066791 WO2022268755A1 (en) | 2021-06-25 | 2022-06-21 | Use of a cosmetic composition for preventing and/or treating cutaneous blackheads |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3124383A1 (en) |
WO (1) | WO2022268755A1 (en) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4540567A (en) | 1976-10-15 | 1985-09-10 | Lever Brothers Company | Cosmetic composition |
JP2920443B2 (en) * | 1991-05-15 | 1999-07-19 | 花王株式会社 | Keratin plug remover |
JP2000351713A (en) * | 1991-05-15 | 2000-12-19 | Kao Corp | Cornoid lamella remover |
US20020022011A1 (en) * | 1998-06-10 | 2002-02-21 | Masaru Hoshi | Blackhead removing sheet and method for producing blackhead removing sheet |
CN101756803A (en) * | 2008-11-26 | 2010-06-30 | 王若松 | Hederagenin-based facial milk cleanser |
US20120073591A1 (en) | 2009-06-01 | 2012-03-29 | Kao Corporation | Method of cleansing |
WO2013018884A1 (en) * | 2011-08-03 | 2013-02-07 | 株式会社資生堂 | Keratotic plug regrowth inhibition agent, keratotic plug regrowth inhibition method, and keratotic plug regrowth inhibition kit |
JP5465831B2 (en) * | 2007-12-18 | 2014-04-09 | ポーラ化成工業株式会社 | Composition for removing horn plugs |
EP3150187A1 (en) | 2015-09-30 | 2017-04-05 | Johnson & Johnson Consumer Inc. | Compositions and methods for treating blackheads |
JP2018021084A (en) | 2013-12-03 | 2018-02-08 | 博 村上 | Liquid cleansing agent for removal of keratotic plug |
FR3044905B1 (en) | 2015-12-11 | 2019-10-25 | L'oreal | USE OF ANTIOXIDANT TO DECREASE THE COLOR DEVELOPMENT OF BLACK POINTS |
-
2021
- 2021-06-25 FR FR2106830A patent/FR3124383A1/en active Pending
-
2022
- 2022-06-21 WO PCT/EP2022/066791 patent/WO2022268755A1/en active Application Filing
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4540567A (en) | 1976-10-15 | 1985-09-10 | Lever Brothers Company | Cosmetic composition |
JP2920443B2 (en) * | 1991-05-15 | 1999-07-19 | 花王株式会社 | Keratin plug remover |
JP2000351713A (en) * | 1991-05-15 | 2000-12-19 | Kao Corp | Cornoid lamella remover |
US20020022011A1 (en) * | 1998-06-10 | 2002-02-21 | Masaru Hoshi | Blackhead removing sheet and method for producing blackhead removing sheet |
JP5465831B2 (en) * | 2007-12-18 | 2014-04-09 | ポーラ化成工業株式会社 | Composition for removing horn plugs |
CN101756803A (en) * | 2008-11-26 | 2010-06-30 | 王若松 | Hederagenin-based facial milk cleanser |
US20120073591A1 (en) | 2009-06-01 | 2012-03-29 | Kao Corporation | Method of cleansing |
WO2013018884A1 (en) * | 2011-08-03 | 2013-02-07 | 株式会社資生堂 | Keratotic plug regrowth inhibition agent, keratotic plug regrowth inhibition method, and keratotic plug regrowth inhibition kit |
JP2018021084A (en) | 2013-12-03 | 2018-02-08 | 博 村上 | Liquid cleansing agent for removal of keratotic plug |
EP3150187A1 (en) | 2015-09-30 | 2017-04-05 | Johnson & Johnson Consumer Inc. | Compositions and methods for treating blackheads |
FR3044905B1 (en) | 2015-12-11 | 2019-10-25 | L'oreal | USE OF ANTIOXIDANT TO DECREASE THE COLOR DEVELOPMENT OF BLACK POINTS |
Also Published As
Publication number | Publication date |
---|---|
FR3124383A1 (en) | 2022-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106580797A (en) | Whitening and freckle-removing cream and preparation method thereof | |
BRPI1003846A2 (en) | 4-hexylresorcinol aqueous concentrates with high clarity | |
EP4228593A1 (en) | Use of thiopyridinone compounds for preventing the formation of cutaneous blackheads | |
WO2013093880A1 (en) | Use of steviol, of a steviol glycoside derivative or of one of their isomers to prevent, reduce and/or treat a detrimental change in the complexion of the skin | |
CN114224787A (en) | Composition containing vegetable seed oil and fat and application thereof | |
US20090023628A1 (en) | Cosmetic Composition and a Process for Preparing This Cosmetic Composition and a Cosmetic Product | |
TW200526259A (en) | Methods for treating skin conditions | |
RU2580622C2 (en) | Composition and use thereof in treating anal fissures | |
CN103494737B (en) | Cosmetic preparation using ginger flower as anti-ageing and skin-protecting factor and preparation method of cosmetic preparation | |
JP3590369B2 (en) | Cosmetic composition for preventing and treating acne containing cryptotanshinone | |
JPH08259433A (en) | Cosmetic or preparation for external use containing humectant composition | |
JP2017193506A (en) | Skin Cosmetic | |
US5641809A (en) | Lanolin/lanolin acid ester skin treatment composition | |
JP4136203B2 (en) | Skin preparation for external use | |
WO1998013436A1 (en) | Humectant composition, base containing the same, and cosmetic material or external preparation containing said humectant composition | |
KR20190079291A (en) | Cosmetic composition containing pseudo-ceramide originated from botanical oil | |
WO2022268755A1 (en) | Use of a cosmetic composition for preventing and/or treating cutaneous blackheads | |
CN110025508A (en) | A kind of essence cream and preparation method thereof preventing striae of pregnancy generation | |
JP2008169196A (en) | External preparation for skin | |
KR101825599B1 (en) | Composition of skin external application for moisturizing the skin containing Oldenlandia diffusa extracts | |
KR20220026801A (en) | Cosmetic composition comprising mixed extract of verbena hybrida voss, cyclamen persicum mill. and saintpaulia ionantha h. wendl. for moisturizing the skin | |
WO2022248459A1 (en) | Use of ascorbyl glucoside for preventing the colouration of cutaneous blackheads. | |
WO2023234345A1 (en) | External skin preparation containing unsaponified concentrate of rice bran oil | |
CN109745262A (en) | A kind of composition for Whitening, spot face cream | |
JPH08119829A (en) | External medicine for skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22735387 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22735387 Country of ref document: EP Kind code of ref document: A1 |